,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,357,2,1,,855848,457964,Inactive,,,,,AP1 Signaling Pathway,Confirmatory,,
1,361,1,2,,855848,457964,Inactive,285623.0,,,,Pyruvate Kinase,Confirmatory,,
2,364,1,3,,855848,457964,Inactive,,,,,Cell Proliferation & Viability (Cytotoxicity) Assay,Confirmatory,,
3,368,2,3,,855848,457964,Inactive,4757950.0,994.0,,,Cdc25B Catalytic Domain protein tyrosine phosphatase  HTS,Screening,,
4,371,1,1,,855848,457964,Active,,,,,Human A549 Lung Tumor Cell Growth Inhibition Assay,Screening,,
5,373,1,4,,855848,457964,Inactive,38788193.0,1903.0,,,S1P3 Agonist Primary HTS and Confirmation Assays,Screening,,
6,374,2,3,,855848,457964,Inactive,4758204.0,1843.0,,,In vitro Primary HTS Assay for MKP-1,Screening,,
7,375,2,3,,855848,457964,Inactive,90108679.0,,,,Mycobacterium tuberculosis Pantothenate Synthetase Assay,Confirmatory,,
8,411,2,1,,855848,457964,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
9,422,1,5,,855848,457964,Inactive,21464101.0,7532.0,,,HTS for 14-3-3 protein interaction modulators,Screening,,
10,425,3,2,,855848,457964,Inactive,16758752.0,116663.0,,IC50,MKP-3 in vitro HTS assay,Confirmatory,,
11,429,1,5,,855848,457964,Inactive,4261762.0,3326.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
12,429,1,5,,855848,457964,Inactive,154146191.0,3320.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
13,430,2,4,,855848,457964,Active,,,,EC50,Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7 cells),Confirmatory,,
14,431,2,4,,855848,457964,Active,,,,EC50,Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7K cells),Confirmatory,,
15,432,2,4,,855848,457964,Inactive,11024684.0,12044.0,,IC50,HTS discovery of chemical inhibitors of anti-apoptotic protein Bfl-1,Confirmatory,,
16,436,2,1,,855848,457964,Inactive,68565074.0,8314.0,,,HTS for BAP1 Enzyme inhibitors,Screening,,
17,438,1,4,,855848,457964,Inactive,223468676.0,5970.0,,,Cellular assay for TNF alpha induced NFkappaB translocation,Screening,,
18,440,3,3,,855848,457964,Inactive,4503779.0,2357.0,,,Primary HTS Assay for Formylpeptide Receptor (FPR) Ligands and Primary HTS Counter-Screen Assay for Formylpeptide-Like-1 (FPRL1) Ligands,Screening,,
19,441,3,3,,855848,457964,Inactive,54112388.0,2358.0,,,Primary HTS Assay for Formylpeptide Receptor-Like-1 (FPRL1) Ligands and Primary HTS Counter-Screen Assay for Formylpeptide Receptor (FPR) Ligands,Screening,,
20,444,1,1,,855848,457964,Inactive,,,,,NFAT Signaling Pathway,Confirmatory,,
21,446,1,1,,855848,457964,Inactive,,,,,Stat Signaling Pathway,Confirmatory,,
22,449,1,5,,855848,457964,Inactive,13027636.0,1901.0,,,Primary HTS and Confirmation Assays for S1P1 Agonists and Agonism Potentiators,Screening,,
23,450,1,2,,855848,457964,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
24,453,2,2,,855848,457964,Inactive,63102437.0,1508.0,,,Cathepsin B,Screening,,
25,454,1,7,,855848,457964,Inactive,,,,,VCAM-1 Plate Reader Assay in Pooled HUVECs: Inhibition of TNFa induced VCAM-1 cell surface expression,Screening,,
26,455,1,7,,855848,457964,Inactive,,,,,VCAM-1 Plate Reader Assay in Pooled HUVECs: Augmentation of TNFa induced VCAM-1 cell surface expression,Screening,,
27,456,1,7,,855848,457964,Inactive,,,,,VCAM-1 Imaging Assay in Pooled HUVECs: Inhibition of TNFa induced VCAM-1 cell surface expression,Screening,,
28,457,1,7,,855848,457964,Inactive,,,,,VCAM-1 Imaging Assay in Pooled HUVECs: Augmentation of TNFa induced VCAM-1 cell surface expression.,Screening,,
29,460,2,2,,855848,457964,Inactive,4503155.0,1514.0,,,Cathepsin L,Screening,,
30,461,1,7,,855848,457964,Inactive,,,,,Isolation of Inhibitors of Her-Kinase Expression,Screening,,
31,483,1,6,,855848,457964,Inactive,296434520.0,3064.0,,,Aggregation and Clearance of Mutant Huntingtin Protein,Screening,,
32,485,1,8,,855848,457964,Inactive,38788193.0,1903.0,,,Primary HTS Assay for S1P3 Antagonists,Screening,,
33,487,1,2,,855848,457964,Inactive,,,,,TNFalpha Induced E-Selectin Expression -  Primary screen,Screening,,
34,488,2,1,,855848,457964,Inactive,63102437.0,1508.0,,,Cathepsin B compound mixture screening,Screening,,
35,501,2,2,,855848,457964,Inactive,23110962.0,1520.0,,,Cathepsin S,Screening,,
36,518,2,6,,855848,457964,Inactive,116734717.0,249.0,,IC50,TNAP luminescent HTS assay,Confirmatory,,
37,521,2,5,,855848,457964,Inactive,18375660.0,5778.0,,IC50,"HTS Discovery of Chemical Inhibitors of HePTP, a Leukemia Target",Confirmatory,,
38,522,1,2,,855848,457964,Inactive,20070193.0,2516.0,,,Primary Cell-based High Throughput Screening assay for activators of the nuclear receptor Steroidogenic Factor 1 (SF-1),Screening,,
39,524,1,3,,855848,457964,Inactive,4506055.0,5566.0,,,Primary biochemical high-throughput screening assay for inhibitors of protein kinase A (PKA) activity,Screening,,
40,525,1,3,,855848,457964,Active,20070193.0,2516.0,,,Primary Cell-based High Throughput Screening assay for inhibitors of the nuclear receptor Steroidogenic Factor 1 (SF-1),Screening,,
41,527,3,1,,855848,457964,Inactive,,,,,Primary HTS Assay for Inhibitors of Bacterial Quorum Sensing,Screening,,
42,528,1,4,,855848,457964,Inactive,67191027.0,3676.0,,,Allosteric Agonists for the VLA-4 Integrin,Screening,,
43,529,1,4,,855848,457964,Inactive,67191027.0,3676.0,,,Allosteric Antagonists for the VLA-4 Integrin,Screening,,
44,538,2,2,,855848,457964,Inactive,4502495.0,716.0,,,Complement factor C1s,Screening,,
45,539,1,2,,855848,457964,Inactive,116077694.0,,,,Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - PMK,Screening,,
46,552,1,3,,855848,457964,Inactive,,,,,Antimicrobial HTS Assay for E. coli BW25113 (wild type),Screening,,
47,555,1,2,,855848,457964,Inactive,116516899.0,,,,Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - MK,Screening,,
48,556,1,3,,855848,457964,Inactive,116076351.0,,,,Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - DPM-DC,Screening,,
49,559,2,2,,855848,457964,Inactive,147728.0,,,,RNA polymerase,Screening,,
50,560,1,2,,855848,457964,Inactive,548814.0,6095.0,,,Primary Cell-based High Throughput Screening assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA),Screening,,
51,561,1,3,,855848,457964,Active,548814.0,6095.0,,,Primary Cell-based High Throughput Screening assay for inhibitors of the Retinoic Acid Receptor-related orphan receptor A (RORA),Screening,,
52,565,1,4,,855848,457964,Inactive,1431733.0,,,,HIV-1 RT-RNase H  MLSCN HTS MH077605,Screening,,
53,567,1,4,,855848,457964,Inactive,55956923.0,3350.0,,,Primary HTS assay for 5-Hydroxytryptamine (Serotonin) Receptor Subtype 1a (5HT1a) agonists,Screening,,
54,568,1,7,,855848,457964,Inactive,5729877.0,3312.0,,IC50,High Throughput Screening Assay for Hsc70 Inhibitors,Confirmatory,,
55,568,1,7,,855848,457964,Inactive,24234686.0,3312.0,,IC50,High Throughput Screening Assay for Hsc70 Inhibitors,Confirmatory,,
56,570,1,4,,855848,457964,Inactive,4505209.0,4322.0,,,Primary biochemical high-throughput screening assay for inhibitors of Matrix Metalloproteinase 13 (MMP13) activity,Screening,,
57,571,1,4,,855848,457964,Inactive,112822.0,3354.0,,,Primary Cell Based High Throughput Screening Assay for Antagonists of the 5-Hydroxytryptamine Receptor Subtype 1E (5HT1E),Screening,,
58,572,1,5,,855848,457964,Inactive,,,,,Human SK-BR-3 Breast Tumor Cell Growth Inhibition In a 24- Hour Assay (Pilot Screen),Screening,,
59,573,1,4,,855848,457964,Inactive,,,,,Primary Antimicrobial Assay for E. coli BW25113 &#8710;tolC::kan Protocol for 384-well HTS,Screening,,
60,574,1,3,,855848,457964,Inactive,112822.0,3354.0,,,Primary Cell Based High Throughput Screening Assay for Agonists of the 5-Hydroxytryptamine Receptor Subtype 1E (5HT1E),Screening,,
61,575,1,4,,855848,457964,Inactive,,,,,Human Endothelial Cell Proliferation Assay,Screening,,
62,576,1,2,,855848,457964,Inactive,67191027.0,3676.0,,,Auto-fluorescence of compounds effecting screening of VLA-4 Integrin,Other,,
63,577,1,1,,855848,457964,Inactive,11528014.0,912267.0,,,HTS to identify Inhibitors of West Nile Virus NS2bNS3 Proteinase,Screening,,
64,580,1,5,,855848,457964,Inactive,,,,,Human H69AR Lung Tumor Cell Growth Inhibition Assay,Screening,,
65,581,2,2,,855848,457964,Inactive,15680217.0,1511.0,,,Cathepsin G,Screening,,
66,583,2,6,,855848,457964,Inactive,123271505.0,,,IC50,High Throughput Screening Assay for Hsp70 Inhibitors,Confirmatory,,
67,587,1,5,,855848,457964,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
68,588,1,4,,855848,457964,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
69,589,1,3,,855848,457964,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
70,590,1,3,,855848,457964,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
71,591,1,4,,855848,457964,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
72,592,1,6,,855848,457964,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
73,593,1,4,,855848,457964,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
74,594,1,4,,855848,457964,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
75,597,1,3,,855848,457964,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
76,599,1,2,,855848,457964,Active,548814.0,6095.0,,,Counterscreen for inhibitors of the nuclear receptor Steroidogenic Factor 1 (SF-1): A cell-based dose-response assay for inhibition of the RAR-related orphan receptor A (RORA),Confirmatory,,
77,600,2,1,,855848,457964,Active,20070193.0,2516.0,,,Dose-response cell-based assay for inhibitors of the nuclear receptor Steroidogenic Factor 1 (SF-1),Confirmatory,,
78,601,1,4,,855848,457964,Inactive,,,,,Identification of Molecular Probes that Reverse MRP-Mediated Drug Resistance Pilot Screen,Screening,,
79,604,1,3,,855848,457964,Inactive,41872583.0,9475.0,,,Primary biochemical high-throughput screening assay for inhibitors of Rho kinase 2 (Rhok2),Screening,,
80,606,1,3,,855848,457964,Inactive,224586929.0,26191.0,,,HTS for LYP Inhibitors-an Autoimmunity Target - Primary screen,Confirmatory,,
81,606,1,3,,855848,457964,Inactive,301171662.0,26191.0,,,HTS for LYP Inhibitors-an Autoimmunity Target - Primary screen,Confirmatory,,
82,609,1,2,,855848,457964,Inactive,,,,,Chemical Complementation Assay for MKP-3,Screening,,
83,610,1,1,,855848,457964,Active,548814.0,6095.0,,,Dose-response cell-based assay for inhibitors of the Retinoic Acid Receptor-related orphan receptor A (RORA),Confirmatory,,
84,611,1,2,,855848,457964,Active,20070193.0,2516.0,,,Counterscreen for inhibitors of the Retinoic Acid Receptor-related orphan receptor A (RORA): A cell-based dose-response assay for inhibition of the Steroidogenic Factor 1 (SF-1),Confirmatory,,
85,614,1,6,,855848,457964,Inactive,116734717.0,249.0,,,HTS colorimetric detection of phosphate released in TNAP reaction,Screening,,
86,615,1,6,,855848,457964,Inactive,116734717.0,249.0,,,HTS colorimetric detection of p-nitrophenol released in TNAP reaction,Screening,,
87,618,2,6,,855848,457964,Inactive,6690534.0,4323.0,,EC50,Luminescent HTS for small molecule inhibitors of MT1-MMP transcription,Confirmatory,,
88,620,2,5,,855848,457964,Inactive,,,,EC50,Fluorescent HTS Cytotoxicity/Cell viability assay (HT1080 cells),Confirmatory,,
89,622,1,2,,855848,457964,Inactive,499328.0,29738.0,,,Voltage-Dependent Potassium Channel Beta Subunit (KvBeta) Negative Modulator Primary Screen,Screening,,
90,623,1,3,,855848,457964,Inactive,499328.0,29738.0,,,Voltage-Dependent Potassium Channel Beta Subunit (KvBeta) Positive Modulator: Primary Screen,Screening,,
91,624,1,2,,855848,457964,Inactive,,,,,Measurement of GPCR-mediated thallium flux through GIRK channels: Primary Screen,Screening,,
92,625,1,2,,855848,457964,Inactive,,,,,Discovery of Novel Allosteric Agonists of the M4 Muscarinic Receptor: Primary Screen,Screening,,
93,626,1,3,,855848,457964,Inactive,,,,,Discovery of Novel Allosteric Modulators of the M1 Muscarinic Receptor: Agonist  Primary Screen,Screening,,
94,628,2,4,,855848,457964,Inactive,113121.0,25229.0,,,Discovery of novel allosteric modulators of the M1 muscarinic receptor: Antagonist Primary Screen,Screening,,
95,631,1,4,,855848,457964,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
96,631,1,4,,855848,457964,Inactive,22538455.0,8648.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
97,641,1,4,,855848,457964,Inactive,,,,,Allosteric Modulators of D1 Receptors: Primary Screen,Screening,,
98,645,1,4,,855848,457964,Active,,,,,Isolation of Inhibitors of Her-Kinase Expression - 66K library screen,Screening,,
99,680,1,10,,855848,457964,Inactive,180352.0,,,,Factor XIa Mixture HTS,Screening,,
100,684,1,12,,855848,457964,Inactive,317373446.0,2161.0,,,Factor XIIa Mixture HTS,Screening,,
101,686,1,1,,855848,457964,Inactive,,,,,Zebrafish Lipid Metabolism Assay---Primary Screen,Screening,,
102,708,1,4,,855848,457964,Inactive,,,,,Profiling the NIH Molecular Libraries Small Molecule Repository: Absorbance at 340 nm,Screening,,
103,709,1,2,,855848,457964,Inactive,,,,,Profiling the NIH Molecular Libraries Small Molecule Repository: Autofluorescence at 339/460 nm,Screening,,
104,731,1,5,,855848,457964,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
105,731,1,5,,855848,457964,Inactive,32307126.0,8202.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
106,734,1,2,,855848,457964,Inactive,4505209.0,4322.0,,,Assay to identify inhibitors among the possible fluorescent artifacts from the primary HTS inhibition assay of Matrix Metalloproteinase 13 (MMP13) activity,Screening,,
107,742,1,4,,855848,457964,Inactive,,,,,Isolation of Inhibitors of Her-Kinase Expression - Dose Response,Confirmatory,,
108,746,1,1,,855848,457964,Inactive,2507196.0,5602.0,,,Primary biochemical high-throughput screening assay for inhibitors of the c-Jun N-Terminal Kinase 3 (JNK3),Screening,,
109,750,1,3,,855848,457964,Inactive,,,,,Luminescent HTS for small molecule activators of MT1-MMP transcription,Screening,,
110,751,1,3,,855848,457964,Inactive,,,,,Disassembly of the 26S Proteasome (ATP Hydrolysis-dependent),Screening,,
111,757,1,4,,855848,457964,Inactive,8574038.0,5879.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac wildtype,Screening,,
112,758,1,4,,855848,457964,Inactive,164058.0,404007.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab7 wildtype,Screening,,
113,759,1,4,,855848,457964,Inactive,190938.0,3265.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype,Screening,,
114,760,1,4,,855848,457964,Inactive,46577642.0,404009.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab2 wildtype,Screening,,
115,761,1,4,,855848,457964,Inactive,56202836.0,,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 wildtype,Screening,,
116,764,1,4,,855848,457964,Inactive,8574038.0,5879.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac activated mutant,Screening,,
117,770,1,1,,855848,457964,Inactive,,,,,Cell Growth High Content Screening Assay of Human HT29 Colon Tumor Cells (24 Hour Treatment Protocol),Screening,,
118,771,1,2,,855848,457964,Inactive,,,,,Cell Growth High Content Screening Assay of Human HT29 Colon Tumor Cells (48 Hour Treatment Protocol),Screening,,
119,772,1,2,,855848,457964,Inactive,,,,,Cell Growth High Content Screening Assay of Human HT29 Colon Tumor Cells (72 Hour Treatment Protocol),Screening,,
120,774,1,2,,855848,457964,Inactive,,,,,Profiling the NIH Molecular Libraries Small Molecule Repository: Inhibition of Enzymes Frequently Used to reach a NAD/NADH Endpoint,Other,,
121,775,1,3,,855848,457964,Inactive,,,,,Screen for Chemicals that Extend Yeast Lifespan,Screening,,
122,781,1,1,,855848,457964,Inactive,27807367.0,287022.0,,,uHTS for 14-3-3/Bad interaction inhibitors,Screening,,
123,782,1,2,,855848,457964,Inactive,83627717.0,13684.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
124,782,1,2,,855848,457964,Inactive,302699239.0,1981.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
125,784,1,4,,855848,457964,Inactive,55584151.0,2629.0,,,Primary Cell Based High Throughput Screening Assay for Enhancers of Beta-Glucosidase Activity,Screening,,
126,793,1,2,,855848,457964,Inactive,4505447.0,4887.0,,,Primary cell based high-throughput screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2),Screening,,
127,795,1,1,,855848,457964,Inactive,,,,,MLSCN Assay for Activators of Prostate Cell Differentiation,Screening,,
128,797,1,1,,855848,457964,Inactive,115529463.0,5587.0,,,Fluorescence polarization assay for PKD inhibitors,Screening,,
129,798,2,12,,855848,457964,Inactive,180352.0,,,,Factor XIa 1536 HTS,Screening,,
130,799,1,5,,855848,457964,Inactive,134142337.0,4363.0,,,Identification of Molecular Probes that Activate MRP-1,Screening,,
131,800,2,11,,855848,457964,Inactive,317373446.0,2161.0,,,Factor XIIa 1536 HTS,Screening,,
132,803,1,4,,855848,457964,Inactive,6016094.0,8811.0,,,Primary cell-based high-throughput screening assay to identify agonists of Galanin Receptor 2 (GALR2),Screening,,
133,804,1,3,,855848,457964,Inactive,,,,,Screen for Chemicals that Shorten Yeast Lifespan,Screening,,
134,813,1,4,,855848,457964,Inactive,116734717.0,249.0,,,HTS identification of compounds activating TNAP at intermediate concentration of phosphate acceptor detected in luminescent assay,Screening,,
135,817,1,1,,855848,457964,Inactive,1360328.0,,,,Identification and characterization of compounds for addressing human bone marrow failure,Other,,
136,818,1,2,,855848,457964,Inactive,,,,,High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression,Screening,,
137,827,1,2,,855848,457964,Inactive,,,,,High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor,Screening,,
138,828,1,5,,855848,457964,Inactive,6016094.0,8811.0,,,Primary cell-based high-throughput screening assay to identify antagonists of Galanin Receptor 2 (GALR2),Screening,,
139,841,1,1,,855848,457964,Inactive,,,,,Non-Nucleoside Inhibitor of Measles Virus RNA-Dependent RNA Polymerase Complex Activity HTS Single Point (MLSMR Library),Screening,,
140,847,1,2,,855848,457964,Inactive,,,,,Human SK-BR-3 Breast Tumor Cell Growth Inhibition In a 24- Hour Assay,Screening,,
141,861,1,1,,855848,457964,Inactive,55662034.0,,,,Primary cell-based high-throughput screening assay for inhibitors of TLR4-MyD88 binding,Screening,,
142,862,1,2,,855848,457964,Inactive,13272532.0,6774.0,,,Primary cell-based high throughput screening assay to measure STAT3 inhibition,Screening,,
143,868,1,3,,855848,457964,Inactive,,,,,Screen for Chemicals that Inhibit the RAM Network,Screening,,
144,871,1,2,,855848,457964,Inactive,13272532.0,6774.0,,,Primary cell-based high throughput screening assay to measure STAT3 activation,Screening,,
145,873,1,13,,855848,457964,Inactive,6912644.0,25818.0,,,Kallikrein 5 1536 HTS,Screening,,
146,878,1,2,,855848,457964,Inactive,,,,,NIH Compound Library Profiling: Compound and DTT Dependent Redox Cycling H2O2 Generation.,Screening,,
147,880,2,1,,855848,457964,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
148,880,2,1,,855848,457964,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
149,880,2,1,,26751530,457964,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
150,880,2,1,,26751530,457964,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
151,894,2,1,,855848,457964,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
152,898,1,1,,855848,457964,Inactive,28373018.0,1239205.0,,,YopH  HTS,Screening,,
153,914,1,3,,855848,457964,Inconclusive,32879895.0,3091.0,1.9953,Potency,qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
154,915,1,3,,855848,457964,Inconclusive,32879895.0,3091.0,1.9953,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
155,920,1,2,,855848,457964,Inactive,6274552.0,6772.0,,,Primary cell-based high throughput screening assay to measure STAT1 inhibition,Screening,,
156,932,1,4,,855848,457964,Inactive,6274552.0,6772.0,,,Primary cell-based high throughput screening assay to measure STAT1 activation,Screening,,
157,940,1,2,,855848,457964,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
158,950,1,1,,855848,457964,Inactive,231632.0,596.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-2.",Screening,,
159,951,1,1,,855848,457964,Inactive,23396469.0,10017.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-B.",Screening,,
160,952,1,1,,855848,457964,Inactive,1572493.0,599.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-W.",Screening,,
161,1001,2,2,,855848,457964,Inactive,116734717.0,249.0,,EC50,uHTS identification of compounds activating TNAP in the absence of phosphate acceptor performed in luminescent assay,Confirmatory,,
162,1006,1,6,,855848,457964,Inactive,,,,,Counter Screen for Luciferase-based Primary Inhibition Assays,Screening,,
163,1007,1,1,,855848,457964,Inactive,510901.0,598.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-XL.",Screening,,
164,1008,1,2,,855848,457964,Inactive,4757840.0,597.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bfl-1",Screening,,
165,1009,1,2,,855848,457964,Inactive,7582271.0,4170.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Mcl-1",Screening,,
166,1012,1,4,,855848,457964,Inactive,116734717.0,249.0,,,uHTS identification of TNAP inhibitors in the absence of phosphate acceptor performed in luminescent assay,Screening,,
167,1016,1,4,,855848,457964,Inactive,68299797.0,280993.0,,,Luminescent assay for identification of activators of bovine intestinal alkaline phosphatase,Screening,,
168,1018,2,5,,855848,457964,Inactive,8744934.0,,,IC50,Chemical Antagonists IAP-family anti-apoptotic proteins,Confirmatory,,
169,1019,1,4,,855848,457964,Inactive,68299797.0,280993.0,,,Luminescent assay for identification of inhibitors of bovine intestinal alkaline phosphatase,Screening,,
170,1020,1,5,,855848,457964,Active,149631.0,,,,Counter Screen for Glucose-6-Phosphate Dehydrogenase-based Primary Assay,Screening,,
171,1021,1,1,,855848,457964,Inactive,7582271.0,4170.0,,,uHTS of Mcl-1/Bid interaction inhibitors,Screening,,
172,1022,1,1,,855848,457964,Inactive,7582271.0,4170.0,,,uHTS of Mcl-1/Noxa interaction inhibitors,Screening,,
173,1027,1,3,,855848,457964,Inactive,,,,,Counter Screen for Luciferase-based Primary Stimulation Assays,Screening,,
174,1030,2,1,,855848,457964,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
175,1030,2,1,,26751530,457964,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
176,1032,1,2,,855848,457964,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
177,1032,1,2,,855848,457964,Inactive,62201602.0,,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
178,1040,1,2,,855848,457964,Inactive,4505445.0,4886.0,,,Primary cell-based high-throughput screening assay for antagonists of NPY-Y1,Screening,,
179,1045,1,2,,855848,457964,Active,,,1.7309999999999999,EC50,High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression - Dose Response,Confirmatory,,
180,1047,1,2,,855848,457964,Active,,,0.8390000000000001,EC50,High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor - Dose Response,Confirmatory,,
181,1048,1,1,,855848,457964,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
182,1048,1,1,,855848,457964,Inactive,32307126.0,8202.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
183,1049,1,1,,855848,457964,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
184,1049,1,1,,855848,457964,Inactive,62201602.0,,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
185,1051,1,1,,855848,457964,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
186,1051,1,1,,855848,457964,Inactive,22538455.0,8648.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
187,1063,1,1,,855848,457964,Active,,,,,Leishmania major promastigote HTS,Screening,,
188,1066,1,2,,855848,457964,Inactive,9937384.0,,,,High Throughput Screen to Identify Compounds that Inhibit Class II HMG-CoA Reductases  - Primary Screen,Screening,,
189,1085,1,1,,855848,457964,Inactive,139424501.0,5176170.0,,,uHTS for Small Molecule Inhibitiors of Epstein-Barr Virus Inhibitors,Screening,,
190,1135,1,3,,855848,457964,Inactive,116734717.0,249.0,,,uHTS identification of compounds inhibiting TNAP at a high concentration of phosphate acceptor detected in a luminescent assay,Screening,,
191,1136,1,3,,855848,457964,Inactive,116734717.0,249.0,,,uHTS identification of compounds activating TNAP at a high concentration of phosphate acceptor detected in a luminescent assay,Screening,,
192,1203,1,3,,855848,457964,Inactive,12803275.0,3303.0,,,Primary cell-based high-throughput screening assay to identify transcriptional activators of heat shock protein 70 (Hsp70),Screening,,
193,1209,2,2,,855848,457964,Inactive,16878311.0,4351.0,,IC50,HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay.,Confirmatory,,
194,1214,1,4,,855848,457964,Inactive,16878311.0,4351.0,,,HTS identification of compounds activating phosphomannose isomerase (PMI) via a fluorescence intensity assay.,Screening,,
195,1216,1,5,,855848,457964,Inactive,16878311.0,4351.0,,,HTS identification of compounds activating phosphomannose isomerase (PMI) via a fluorescence intensity assay using a near- saturating concentration of mannose 6-phosphat,Screening,,
196,1217,1,4,,855848,457964,Inactive,17391426.0,1738.0,,,uHTS Identification of Diaphorase Inhibitors and Chemcical Oxidizers: Counter Screen for Diaphorase-based Primary Assays,Screening,,
197,1220,2,2,,855848,457964,Inactive,16878311.0,4351.0,,IC50,HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay using a high concentration of mannose 6-phosphate,Confirmatory,,
198,1222,1,6,,855848,457964,Inactive,,,,EC50,High Throughput Screen for Inhibitors of ER Stress-induced Cell Death in a 384 well format.,Confirmatory,,
199,1229,1,3,,855848,457964,Inactive,17391426.0,1738.0,,,uHTS Identification of Diaphorase Activators and Chemical Reducers: Counter Screen for Diaphorase-based Primary Assays,Screening,,
200,1235,1,2,,855848,457964,Inactive,,,,,Alternative Pathway ELISA_orthogonal screening,Screening,,
201,1236,1,1,,855848,457964,Inactive,1628587.0,397393.0,,,uHTS for Calpain Inhibitors,Screening,,
202,1239,1,3,,855848,457964,Inactive,34577122.0,4790.0,,,High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen,Screening,,
203,1239,1,3,,855848,457964,Inactive,223468676.0,5970.0,,,High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen,Screening,,
204,1242,1,1,,855848,457964,Inactive,11094021.0,,,,C. albicans biofilm killing---Mixture HTS,Screening,,
205,1251,1,1,,855848,457964,Inactive,,,,,"Anti-Viral Drugs Against Arbovirus Infections, a Primary Screen",Screening,,
206,1258,1,1,,855848,457964,Active,,,,,Leishmania major promastigote HTS - primary screen repeat 1 uM,Screening,,
207,1273,1,1,,855848,457964,Inactive,59036749.0,3630.0,,,Primary screen for compounds that inhibit Insulin promoter activity in TRM-6 cells,Screening,,
208,1274,1,2,,855848,457964,Inactive,115298672.0,653361.0,,,"uHTS of small molecular inhibitors for p47phox, a regulatory protein of NADPH oxidases (Noxs)",Screening,,
209,1276,1,1,,855848,457964,Inactive,257380.0,351.0,,,Primary screen for compounds that activate Alzheimer's amyloid precursor,Screening,,
210,1285,1,1,,855848,457964,Active,257380.0,351.0,,,Primary screen for compounds that inhibit Alzheimer's amyloid precursor protein (APP) translation,Screening,,
211,1296,1,1,,855848,457964,Inactive,59036749.0,3630.0,,,Primary screen for compounds that activate Insulin promoter activity in TRM-6 cells,Screening,,
212,1304,1,2,,855848,457964,Inactive,4505445.0,4886.0,,,Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y1,Screening,,
213,1321,1,2,,855848,457964,Inactive,47123300.0,7465.0,,,Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation,Screening,,
214,1325,1,2,,855848,457964,Inactive,62526033.0,9429.0,,,"High-throughput multiplex screening for ABC transporter inhibitors: specifically ABCG2 screen, ABCB1 counter-screen",Screening,,
215,1326,1,4,,855848,457964,Inactive,42741659.0,5243.0,,,"High-throughput multiplex screening for ABC transporter inhibitors: specifically ABCB1 screen, ABCG2 counter-screen",Screening,,
216,1359,1,4,,855848,457964,Inactive,4505447.0,4887.0,,,Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y2,Screening,,
217,1362,1,2,,855848,457964,Inactive,,,,,Chemical Genetic Screen to Identify Inhibitors of Mitochondrial Fusion - Primary Screen,Screening,,
218,1376,1,2,,855848,457964,Inactive,15608158.0,886069.0,,IC50,Inhibitors of Mycobacterial Glucosamine-1-phosphate acetyl transferase (GlmU),Confirmatory,,
219,1377,1,1,,855848,457964,Inactive,,,,,HTS to identify inhibitors of zVAD Induced Cell Death in L929 Cells.,Screening,,
220,1379,1,2,,855848,457964,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
221,1381,1,1,,855848,457964,Inactive,,,,,HCS to Identify Inhibitors of Dynein Mediated Cargo Transport on Microtubules.,Screening,,
222,1385,2,2,,855848,457964,Inactive,49168602.0,5888.0,,,Homologous recombination - Rad 51,Screening,,
223,1415,1,2,,855848,457964,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
224,1415,1,2,,855848,457964,Inactive,86301151.0,5999.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
225,1416,1,2,,855848,457964,Inactive,134304838.0,9451.0,,,Primary cell-based high-throughput screening assay to measure PERK inhibition,Screening,,
226,1422,1,1,,855848,457964,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
227,1423,1,2,,855848,457964,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
228,1423,1,2,,855848,457964,Inactive,74355113.0,85397.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
229,1424,1,1,,855848,457964,Inactive,34330186.0,368273.0,,,Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel N1 (TRPN1),Screening,,
230,1430,1,1,,855848,457964,Inactive,70832125.0,3663016.0,,,HTS assay for inhibitors of Trypanosoma brucei hexokinase 1,Screening,,
231,1434,2,3,,855848,457964,Inactive,13124881.0,865.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
232,1434,2,3,,855848,457964,Inactive,19923198.0,861.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
233,1439,1,1,,855848,457964,Inactive,1166512.0,6000.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
234,1439,1,1,,855848,457964,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
235,1440,1,1,,855848,457964,Inconclusive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
236,1440,1,1,,855848,457964,Inconclusive,86990435.0,10287.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
237,1441,1,1,,855848,457964,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
238,1441,1,1,,855848,457964,Inactive,156416009.0,6004.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
239,1443,1,3,,855848,457964,Inactive,4507593.0,8743.0,,,uHTS for the identification of compounds that potentiate TRAIL-induced apoptosis of cancer cells,Screening,,
240,1445,1,1,,855848,457964,Inactive,124512980.0,813945.0,,IC50,Inhibitors of Plasmodium falciparum M1- Family Alanyl Aminopeptidase (M1AAP),Confirmatory,,
241,1446,1,3,,855848,457964,Active,119579178.0,3717.0,,,Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F,Screening,,
242,1448,1,3,,855848,457964,Inactive,38174238.0,55283.0,,,Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel ML3 (TRPML3),Screening,,
243,1452,1,1,,855848,457964,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
244,1456,1,1,,855848,457964,Inactive,12003227.0,57468.0,,,Identification of Novel Modulators of Cl- dependent Transport Process via HTS: Primary Screen,Other,,
245,1457,1,1,,855848,457964,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
246,1457,1,1,,26751530,457964,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
247,1458,1,1,,855848,457964,Inactive,10937869.0,6607.0,2.2387,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
248,1458,1,1,,26751530,457964,Inactive,10937869.0,6607.0,0.7943,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
249,1460,1,3,,855848,457964,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
250,1460,1,3,,26751530,457964,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
251,1461,1,2,,855848,457964,Inactive,46395496.0,387129.0,,Potency,qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction,Confirmatory,,
252,1463,1,1,,855848,457964,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
253,1463,1,1,,26751530,457964,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
254,1465,1,1,,855848,457964,Inactive,,,,EC50,"Screen for small molecule probes relevant to Friedreich's ataxia, Single Dose and Dose Response",Confirmatory,,
255,1466,1,2,,855848,457964,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease,Confirmatory,,
256,1468,1,1,,855848,457964,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
257,1468,1,1,,26751530,457964,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
258,1469,1,1,,855848,457964,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
259,1469,1,1,,26751530,457964,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
260,1471,2,1,,26751530,457964,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
261,1476,2,1,,855848,457964,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
262,1477,1,1,,855848,457964,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
263,1477,1,1,,26751530,457964,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
264,1478,2,1,,855848,457964,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
265,1479,1,2,,855848,457964,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
266,1479,1,2,,26751530,457964,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
267,1481,1,2,,855848,457964,Inactive,111305821.0,7415.0,,,Primary biochemical high-throughput screening assay to measure P97 ATPase inhibition,Screening,,
268,1486,1,3,,855848,457964,Active,,,,,Counterscreen for inhibitors of Janus kinase 2 mutant JAK2V617F: Cell-based high throughput assay to identify inhibitors of parental Ba/F3 cell viability.,Screening,,
269,1487,1,1,,855848,457964,Inconclusive,27436948.0,4000.0,0.7943,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
270,1490,2,1,,855848,457964,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
271,1490,2,1,,26751530,457964,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
272,1496,1,4,,855848,457964,Inactive,13124881.0,865.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
273,1496,1,4,,855848,457964,Inactive,19923198.0,861.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
274,1509,1,2,,855848,457964,Inactive,15929025.0,8698.0,,,Primary Cell-Based Assay to Identify Agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4),Screening,,
275,1510,1,3,,855848,457964,Inactive,15929025.0,8698.0,,,Primary Cell-Based Assay to Identify Antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4),Screening,,
276,1511,1,3,,855848,457964,Inactive,487738.0,3757.0,,,Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents,Screening,,
277,1515,1,2,,855848,457964,Inactive,24119166.0,10741.0,,,Primary biochemical high throughput screening assay to identify inhibitors of Retinoblastoma binding protein 9 (RBBP9),Screening,,
278,1527,1,3,,855848,457964,Inactive,7381449.0,14678525.0,,,Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase,Screening,,
279,1529,1,1,,855848,457964,Inactive,42794767.0,4215.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype",Screening,,
280,1530,1,1,,855848,457964,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant",Screening,,
281,1531,1,1,,855848,457964,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype",Screening,,
282,1532,1,1,,855848,457964,Inactive,,,,,Rml C and D inhibition 384-well mixture HTS,Screening,,
283,1554,1,1,,855848,457964,Inactive,,,,,MLPCN Ras selective lethality-BJeLR viability,Screening,,
284,1556,1,4,,855848,457964,Inactive,27368096.0,,,,Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase,Screening,,
285,1565,2,2,,855848,457964,Inactive,219689097.0,162466.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit PHOSPHO1,Confirmatory,,
286,1566,2,3,,855848,457964,Inactive,11545912.0,64127.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD2,Confirmatory,,
287,1578,3,2,,855848,457964,Inactive,5174617.0,10392.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD1,Confirmatory,,
288,1619,1,2,,855848,457964,Inactive,124809582.0,812021.0,,IC50,Inhibitors of Plasmodium falciparum M17- Family Leucine Aminopeptidase (M17LAP),Confirmatory,,
289,1621,1,2,,855848,457964,Inactive,,,,IC50,A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus,Confirmatory,,
290,1626,1,2,,855848,457964,Inactive,,,,IC50,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
291,1631,3,1,,855848,457964,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
292,1634,3,1,,855848,457964,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
293,1654,2,2,,855848,457964,Inactive,4758208.0,1845.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit VHR1.,Confirmatory,,
294,1656,2,2,,855848,457964,Inactive,,,,,High Throughput Imaging Assay for Hepatic Lipid Droplet Formation,Screening,,
295,1662,1,2,,855848,457964,Inactive,15675770.0,901648.0,,,MLPCN Streptokinase Expression Inhibition,Screening,,
296,1663,1,2,,855848,457964,Inactive,,,,,MLPCN Platelet Activation -Dense Granule Release,Screening,,
297,1665,2,2,,855848,457964,Inactive,4503131.0,1499.0,,IC50_Mean,High Throughput Imaging Assay for Beta-Catenin,Confirmatory,,
298,1672,1,3,,855848,457964,Inactive,6680530.0,16518.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1,Screening,,
299,1700,1,2,,855848,457964,Inactive,124263658.0,688.0,,,Primary cell-based high throughput screening assay to identify inhibitors of kruppel-like factor 5 (KLF5),Screening,,
300,1706,1,2,,855848,457964,Inactive,73745819.0,,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro),Screening,,
301,1721,1,2,,855848,457964,Inactive,290753097.0,,,Potency,qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
302,1722,1,2,,855848,457964,Inactive,290753097.0,,,Potency,qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
303,1766,1,1,,855848,457964,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
304,1766,1,1,,855848,457964,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
305,1768,1,1,,855848,457964,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
306,1768,1,1,,855848,457964,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
307,1775,1,2,,855848,457964,Inactive,,,,,Profiling compound fluorescence on Avidin Beads with 488 nm excitation and 530 nm emission,Other,,
308,1776,1,2,,855848,457964,Inactive,,,,,Profiling compound fluorescence on GSH Beads with 488 nm excitation and 530 nm emission,Other,,
309,1777,3,2,,855848,457964,Inactive,39725940.0,4986.0,,EC50,uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
310,1778,3,3,,855848,457964,Inactive,39725940.0,4986.0,,IC50,uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
311,1779,2,2,,855848,457964,Inactive,224586929.0,26191.0,,IC50,uHTS identification of small molecule inhibitors of LYP via a fluorescence intensity assay,Confirmatory,,
312,1789,1,2,,855848,457964,Inactive,83318444.0,3320.0,,,Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90),Screening,,
313,1800,1,2,,855848,457964,Inactive,125541954.0,,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3),Screening,,
314,1813,1,2,,855848,457964,Active,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors,Screening,,
315,1814,1,2,,855848,457964,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators,Screening,,
316,1817,2,2,,855848,457964,Inactive,40849930.0,5339.0,,IC50,uHTS identification of small molecule antagonists of the binding of Siah-1 and a peptide ligand via a fluorescence polarization assay.,Confirmatory,,
317,1822,1,3,,855848,457964,Inactive,23505220.0,813594.0,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP).,Screening,,
318,1825,1,1,,855848,457964,Active,,,,,Luminescence-based counterscreen assay for KLF5 inhibitors: cell-based high throughput screening assay to identify cytotoxic compounds using the IEC-6 intestinal epithelial cell line.,Screening,,
319,1832,2,1,,855848,457964,Inactive,55976631.0,178296.0,,,MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen,Screening,,
320,1845,1,2,,855848,457964,Inactive,125541954.0,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID),Screening,,
321,1850,2,1,,855848,457964,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
322,1861,2,1,,855848,457964,Inactive,119607128.0,2831.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7).,Screening,,
323,1862,1,4,,855848,457964,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_RPL19A,Screening,,
324,1863,2,1,,855848,457964,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
325,1865,1,1,,855848,457964,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
326,1865,1,1,,26751530,457964,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
327,1867,1,4,,855848,457964,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_MEP2,Screening,,
328,1868,1,4,,855848,457964,Inactive,4503895.0,2584.0,,Potency,qHTS Assay for Inhibitors of Human Galactokinase (GALK),Confirmatory,,
329,1870,1,4,,855848,457964,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_CIT2,Screening,,
330,1873,1,4,,855848,457964,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_LAP4,Screening,,
331,1875,2,1,,855848,457964,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Polyadenylation,Screening,,
332,1885,2,1,,855848,457964,Inactive,,,,,Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication,Screening,,
333,1887,1,4,,855848,457964,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_AGP1,Screening,,
334,1899,1,3,,855848,457964,Inactive,83779224.0,,,,TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization,Screening,,
335,1903,2,3,,855848,457964,Inactive,297591903.0,29031019.0,,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
336,1906,1,3,,855848,457964,Inactive,55958172.0,,,,QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1).,Screening,,
337,1907,1,2,,855848,457964,Active,,,,,Luminescence-based confirmation cell-based assay for cytotoxic compounds using the IEC-6 intestinal epithelial cell line.,Screening,,
338,1910,1,2,,855848,457964,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Transcriptional Activators of Hypoxia-Inducible Factor Pathway,Screening,,
339,1933,1,1,,855848,457964,Active,,,38.639,EC50,Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to BJ-TERT RAS-Independent Fibroblast,Confirmatory,,
340,1934,1,1,,855848,457964,Inconclusive,,,150.0,EC50,Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to DRD Non-Viral Oncogenic Fibroblast,Confirmatory,,
341,1935,1,1,,855848,457964,Inactive,,,150.0,EC50,Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to BJ-TERT-LT-ST RAS-Independent Fibroblast,Confirmatory,,
342,1936,1,1,,855848,457964,Active,,,28.62,EC50,Luminescence Cell-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to BJeLR RAS-Dependent Fibroblast,Confirmatory,,
343,1947,1,2,,855848,457964,Inactive,21595511.0,226016.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B.,Screening,,
344,1950,1,3,,855848,457964,Inactive,23893623.0,3783709.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1).,Screening,,
345,1956,1,1,,855848,457964,Inactive,,,,Conc @ Max Fold Increase,A high-throughput screen to identify small molecule compounds that augment HSV replication,Confirmatory,,
346,1961,2,2,,855848,457964,Inactive,33695107.0,9290.0,,EC50,Image-based HTS for Selective Agonists of GPR55,Confirmatory,,
347,1962,1,2,,855848,457964,Inactive,68476498.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Screening,,
348,1974,1,2,,855848,457964,Inactive,4758484.0,9446.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1).,Screening,,
349,1984,1,3,,855848,457964,Inactive,118026946.0,17979.0,,IC50,Fluorescence for the identification of compounds that decrease p/CIP protein stability,Confirmatory,,
350,1986,1,2,,855848,457964,Inactive,45357394.0,,,IC50,uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors.,Confirmatory,,
351,1987,1,2,,855848,457964,Inactive,37589898.0,5536.0,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5).,Screening,,
352,2006,3,2,,855848,457964,Inactive,4507785.0,7329.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
353,2006,3,2,,855848,457964,Inactive,13111961.0,10054.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
354,2006,3,2,,855848,457964,Inactive,17390638.0,10055.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
355,2008,1,2,,855848,457964,Active,,,0.136,DR_EC50uM_Run1,Leishmania major promastigote EC50 determinations,Confirmatory,,
356,2012,3,2,,855848,457964,Inactive,45219878.0,7458.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H),Confirmatory,,
357,2013,2,2,,855848,457964,Inactive,33695107.0,9290.0,,IC50,Image-Based HTS for Selective Antagonists for GPR55,Confirmatory,,
358,2014,3,2,,855848,457964,Inactive,46367787.0,26986.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (PABP),Confirmatory,,
359,2016,1,3,,855848,457964,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN.,Screening,,
360,2023,1,3,,855848,457964,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN.,Screening,,
361,2025,1,3,,855848,457964,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN.,Screening,,
362,2029,1,3,,855848,457964,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN.,Screening,,
363,2052,2,1,,855848,457964,Inactive,124486680.0,16408.0,,,HTS for developing T Cell Immune Modulators,Screening,,
364,2057,1,2,,855848,457964,Inactive,78070770.0,4170.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
365,2058,3,2,,855848,457964,Inactive,33695097.0,2859.0,,IC50,Image-Based HTS for Selective Antagonists of GPR35,Confirmatory,,
366,2066,1,4,,855848,457964,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN.,Screening,,
367,2071,2,2,,855848,457964,Inactive,14719829.0,22861.0,,,Colorimetric  Assay for Inhibitors for NALP1,Screening,,
368,2073,2,3,,855848,457964,Inactive,2625023.0,83589.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
369,2073,2,3,,855848,457964,Inactive,4502523.0,774.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
370,2094,1,2,,855848,457964,Inactive,67463988.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
371,2094,1,2,,855848,457964,Inactive,67463989.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
372,2094,1,2,,855848,457964,Inactive,166202459.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
373,2097,1,2,,855848,457964,Inactive,21361340.0,2932.0,,,Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity,Screening,,
374,2098,1,1,,855848,457964,Inactive,62740231.0,15499.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1).,Screening,,
375,2099,1,1,,855848,457964,Inactive,,,,,Fluorescence Biochemical Primary HTS to Identify Inhibitors of GASC-1 Activity,Screening,,
376,2100,1,1,,855848,457964,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen,Confirmatory,,
377,2101,1,1,,855848,457964,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
378,2101,1,1,,26751530,457964,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
379,2107,1,1,,855848,457964,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
380,2107,1,1,,26751530,457964,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
381,2112,1,1,,855848,457964,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
382,2112,1,1,,26751530,457964,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
383,2129,1,2,,855848,457964,Inactive,510901.0,598.0,,,"Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
384,2130,1,3,,855848,457964,Inactive,7706645.0,51400.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
385,2147,1,1,,855848,457964,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
386,2156,2,2,,855848,457964,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels,Screening,,
387,2174,1,3,,855848,457964,Inactive,5453722.0,10434.0,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1).,Screening,,
388,2177,1,3,,855848,457964,Inactive,4581413.0,,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2).,Screening,,
389,2205,1,1,,855848,457964,Inactive,29788785.0,203068.0,,,HCS assay for microtubule stabilizers,Screening,,
390,2216,1,3,,855848,457964,Inactive,,,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex,Screening,,
391,2221,1,2,,855848,457964,Inactive,15609874.0,888371.0,,,Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of RecA Intein Splicing Activity,Screening,,
392,2227,1,2,,855848,457964,Inactive,2935630.0,22066.0,,,Primary cell-based high-throughput screening assay for identification of compounds that allosterically potentiate transient receptor potential cation channel C4 (TRPC4),Screening,,
393,2234,1,2,,855848,457964,Inactive,82503229.0,3783744.0,,,"Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA.",Screening,,
394,2235,1,2,,855848,457964,Inactive,56790945.0,5499.0,,,Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).,Screening,,
395,2237,1,2,,855848,457964,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4).,Screening,,
396,2239,1,2,,855848,457964,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels,Screening,,
397,2242,1,1,,855848,457964,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease,Confirmatory,,
398,2247,1,2,,855848,457964,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that inhibit transient receptor potential cation channel C4 (TRPC4).,Screening,,
399,2280,2,3,,855848,457964,Inactive,17507875.0,172532.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.,Screening,,
400,2288,1,1,,855848,457964,Inactive,,,,Potency,qHTS Assay for Modulators of miRNAs and/orActivators of miR-21,Confirmatory,,
401,2289,1,1,,855848,457964,Inactive,,,,Potency,qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21,Confirmatory,,
402,2300,1,3,,855848,457964,Inactive,216409728.0,10002.0,,,"TR-FRET-based primary biochemical high throughput screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3).",Screening,,
403,2314,1,2,,855848,457964,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
404,2314,1,2,,855848,457964,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
405,2315,1,2,,855848,457964,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
406,2315,1,2,,855848,457964,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
407,2326,1,1,,855848,457964,Inactive,194352380.0,,,Potency,qHTS Assay for Inhibitors of Influenza NS1 Protein Function,Confirmatory,,
408,2391,1,1,,855848,457964,Inactive,,,,IC50,A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV),Confirmatory,,
409,2417,1,1,,855848,457964,Inconclusive,4506243.0,5725.0,,,High Content Assay for Compounds that inhibit the Assembly of the Perinucleolar Compartment,Screening,,
410,2435,1,2,,855848,457964,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR).,Screening,,
411,2445,1,2,,855848,457964,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR),Screening,,
412,2451,1,2,,855848,457964,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
413,2462,1,1,,855848,457964,Inactive,20336315.0,10018.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
414,2462,1,1,,855848,457964,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
415,2472,1,2,,855848,457964,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
416,2517,2,1,,855848,457964,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
417,2517,2,1,,26751530,457964,Inconclusive,6980812.0,,39.8107,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
418,2523,1,1,,855848,457964,Inactive,124486680.0,16408.0,,,HTS of MLPCN Validation Compound Set for developing T Cell Immune Modulators,Screening,,
419,2528,1,2,,855848,457964,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
420,2546,1,1,,855848,457964,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
421,2549,1,1,,855848,457964,Inconclusive,282403581.0,,5.6234,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
422,2549,1,1,,26751530,457964,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
423,2550,1,3,,855848,457964,Inactive,160333370.0,22068.0,,,High throughput screening of activators of transient receptor potential cation channel C6 (TRPC6),Screening,,
424,2551,1,1,,855848,457964,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
425,2553,1,2,,855848,457964,Inactive,160333370.0,22068.0,,,High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6),Screening,,
426,2557,1,3,,855848,457964,Inactive,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library,Screening,,
427,2563,1,1,,855848,457964,Inactive,6323930.0,855317.0,,,Fluorescence Cell-Free Homogenous Primary HTS  to Identify Inhibitors of the Ras-converting Enzyme,Screening,,
428,2606,1,2,,855848,457964,Inactive,15610807.0,885176.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the membrane-associated serine protease Rv3671c in M.tuberculosis,Screening,,
429,2629,1,1,,855848,457964,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
430,2642,1,2,,855848,457964,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels,Screening,,
431,2648,1,2,,855848,457964,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels,Screening,,
432,2650,2,1,,855848,457964,Inactive,49574532.0,2931.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha,Screening,,
433,2661,1,1,,855848,457964,Inactive,23943882.0,65975.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine  Kinase 33  Activity,Screening,,
434,2662,2,1,,855848,457964,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
435,2669,1,1,,855848,457964,Inactive,90903231.0,3064.0,,Potency,qHTS Assay Multiplex Screening to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (Protease relase),Confirmatory,,
436,2673,1,1,,855848,457964,Inactive,90903231.0,3064.0,0.631,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection confirmation (ATP),Confirmatory,,
437,2674,1,1,,855848,457964,Inactive,34810098.0,,,,HTS for Identification of VLA-4 Allosteric Modulators from Validation Compound Set.,Screening,,
438,2675,1,1,,855848,457964,Inactive,41281591.0,4154.0,,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding,Confirmatory,,
439,2676,1,2,,855848,457964,Inactive,85986601.0,59350.0,,Potency,qHTS Assay for Agonists of the Relaxin Receptor RXFP1,Confirmatory,,
440,2685,1,1,,855848,457964,Inconclusive,,,0.20600000000000002,Potency,qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells,Confirmatory,,
441,2690,1,2,,855848,457964,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide,Screening,,
442,2706,1,1,,855848,457964,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide for Validation Compound Set,Screening,,
443,2716,1,1,,855848,457964,Inactive,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
444,2717,1,2,,855848,457964,Inconclusive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells,Screening,,
445,2718,1,1,,855848,457964,Inactive,13128862.0,8841.0,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone Deacetylase 3,Screening,,
446,2732,1,1,,855848,457964,Inactive,160707929.0,13198.0,,,HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress,Screening,,
447,2751,2,2,,855848,457964,Inactive,153217451.0,9581.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL),Screening,,
448,2796,1,4,,855848,457964,Inactive,4502003.0,196.0,,,Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR),Screening,,
449,2797,1,2,,855848,457964,Inactive,4502331.0,552.0,,,Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R),Screening,,
450,35822,9,2,,103199841,457964,Active,,,3.0,IC50,Compound was evaluated for the inhibitory activity against Human alpha polymerase,Confirmatory,10999475.0,
451,53467,6,2,,103199841,457964,Active,,,5.0,EC50,Effective concentration against DNA polymerase of Herpes simplex virus 2 (HSV-2),Confirmatory,8246219.0,
452,53667,9,2,,103199841,457964,Active,,,2.0,EC50,Effective concentration against DNA polymerase alpha,Confirmatory,8246219.0,
453,55151,3,4,,103199841,457964,Unspecified,,,,,Ability of compound to inhibit DNA synthesis against the uptake of [3H]thymidine in freshly seeded cultures of SV-40 transformed WI-38 human lung fibroblast at a concentration 0.15 ug/mL.,Other,6090666.0,
454,82561,8,2,,103199841,457964,Inconclusive,,,,,"Antiviral activity in a cell-based plaque reduction assay, using an HFF cell line and the Davis strain of HCMV; no data",Other,10999475.0,
455,83746,7,1,,103199841,457964,Active,,,,,Minimum antiviral concentration proved to be lethal to viral population in uM,Other,10956199.0,
456,83747,5,1,,103199841,457964,Unspecified,,,,,Minimum antiviral concentration proved to be lethal to viral population in ug/mL.,Other,10956199.0,
457,83917,3,3,,103199841,457964,Unspecified,,,,,In vitro antiviral activity against Herpes Simplex-1 virus (HSV-1) expressed as percent reduction in the number of viral plaques,Other,10956199.0,
458,86064,6,2,,103199841,457964,Active,,,0.59,IC50,Concentration which caused 50% loss of the monolayer present around the viral plaques in uM,Confirmatory,10956199.0,
459,86065,6,2,,103199841,457964,Unspecified,,,,,Concentration which caused 50% loss of the monolayer present around the viral plaques in ug/mL.,Other,10956199.0,
460,86334,3,5,,103199841,457964,Unspecified,,,,,Compound was evaluated for the effect on [3H]- Uridine incorporation by HeLa cells and percentage inhibition into DNA,Other,3806587.0,
461,86335,3,5,,103199841,457964,Unspecified,,,,,Compound was evaluated for the effect on [3H]- Uridine incorporation by HeLa cells and percentage inhibition into RNA,Other,3806587.0,
462,160323,9,3,,103199841,457964,Active,,,0.4,IC50,Inhibitory activity against Human Cytomegalovirus (HCMV) polymerase,Confirmatory,10999475.0,
463,255106,9,5,,103199841,457964,Active,60392197.0,5422.0,2.6,IC50,Inhibition of human alpha DNA polymerase (95 uL) activity in a solution containg 6.4 mM HEPES (pH 7.5) upon incubation for 12 minutes at 26 degrees C with the compound dissolved in DMSO,Confirmatory,16134946.0,
464,255107,9,5,,103199841,457964,Unspecified,50403732.0,5424.0,40.0,IC50,Inhibition of human delta DNA polymerase (95 uL) activity in a solution containg 6.4 mM HEPES (pH 7.5) upon incubation for 12 minutes at 26 degrees C with the compound dissolved in DMSO,Confirmatory,16134946.0,
465,255119,9,2,,103199841,457964,Active,,,0.4,IC50,"Inhibition of human cytomegalovirus DNA polymerase (95 uL) activity in a solution containing 6.4 mM HEPES (pH 7.5), incubation for 12 minutes at 26 degrees C",Confirmatory,16134946.0,
466,255124,9,2,,103199841,457964,Active,,,0.6,IC50,"Inhibition of Varicella-Zoster virus DNA polymerase (95 uL) activity in a solution containing 6.4 mM HEPES (pH 7.5), incubation for 12 minutes at 26 degrees C",Confirmatory,16134946.0,
467,255129,9,2,,103199841,457964,Active,,,0.5,IC50,"Inhibition of herpes simplex virus type 1 DNA polymerase (95 uL) activity in a solution containing 6.4 mM HEPES (pH 7.5), incubation for 12 minutes at 26 degrees C",Confirmatory,16134946.0,
468,299437,6,2,,103199841,457964,Active,,,0.4,IC50,Inhibition of human cytomegalovirus DNA polymerase,Confirmatory,17513108.0,
469,299440,6,2,,103199841,457964,Active,,,0.5,IC50,Inhibition of HSV1 DNA polymerase,Confirmatory,17513108.0,
470,299441,6,2,,103199841,457964,Active,,,0.6,IC50,Inhibition of VZV DNA polymerase,Confirmatory,17513108.0,
471,299442,6,2,,103199841,457964,Active,,,2.6,IC50,Inhibition of human DNA polymerase alpha,Confirmatory,17513108.0,
472,307427,7,2,,103199841,457964,Active,,,0.48700000000000004,IC50,Inhibition of HCMV DNA polymerase by scintillation proximity assay,Confirmatory,17434304.0,
473,307428,4,3,,103199841,457964,Active,,,0.43799999999999994,IC50,Inhibition of HSV1 DNA polymerase by scintillation proximity assay,Confirmatory,17434304.0,
474,307429,4,3,,103199841,457964,Active,,,0.473,IC50,Inhibition of VZV DNA polymerase by scintillation proximity assay,Confirmatory,17434304.0,
475,307435,4,3,,103199841,457964,Active,,,2.6,IC50,Inhibition of human DNA polymerase alpha by scintillation proximity assay,Confirmatory,17434304.0,
476,324379,3,4,,103199841,457964,Unspecified,,,,,Induction of light chain 3-GFP level in human H4 cells at 7.4 uM after 24 hrs by high throughput fluorescence microscopy relative to control,Other,18024584.0,
477,324431,3,4,,103199841,457964,Unspecified,,,,,Increase in light chain 3-GFP+ autophagosome vesicle number per cell in human H4 cells at 7.4 uM after 24 hrs by high throughput fluorescence microscopy relative to control,Other,18024584.0,
478,324482,3,4,,103199841,457964,Unspecified,,,,,Increase in light chain 3-GFP+ autophagosome vesicle area per cell in human H4 cells at 11.3 uM after 24 hrs by high throughput fluorescence microscopy relative to control,Other,18024584.0,
479,324534,3,4,,103199841,457964,Unspecified,,,,,Increase in light chain 3-GFP+ autophagosome vesicle intensity per cell in human H4 cells at 11.3 uM after 24 hrs by high throughput fluorescence microscopy relative to control,Other,18024584.0,
480,340464,4,3,,103199841,457964,Active,,,0.48700000000000004,IC50,Inhibition of HCMV DNA polymerase by scintillation proximity assay,Confirmatory,18595689.0,
481,340465,7,2,,103199841,457964,Active,,,0.43799999999999994,IC50,Inhibition of HSV1 DNA polymerase by scintillation proximity assay,Confirmatory,18595689.0,
482,340466,4,3,,103199841,457964,Active,,,0.473,IC50,Inhibition of VZV DNA polymerase by scintillation proximity assay,Confirmatory,18595689.0,
483,340467,4,3,,103199841,457964,Active,,,2.6,IC50,Inhibition of human polymerase alpha by scintillation proximity assay,Confirmatory,18595689.0,
484,357848,3,5,,103199841,457964,Unspecified,,,,,Antiviral activity against HSV1 in african green monkey Vero cells assessed as reduction in number of plaques at 0.005 mg/ml after 66 hrs,Other,1667410.0,
485,357849,6,3,,103199841,457964,Unspecified,,,,,Cytotoxicity against african green monkey Vero cells after 66 hrs,Other,1667410.0,
486,399272,5,1,,103199841,457964,Unspecified,,,,,In vivo antitumor activity against mouse P388 cells,Other,6434698.0,
487,434955,1,2,,855848,457964,Inactive,,,,IC90,Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics,Confirmatory,,
488,434962,1,2,,855848,457964,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE),Screening,,
489,434989,1,1,,855848,457964,Inactive,222080095.0,3061.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
490,435005,1,1,,855848,457964,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis.,Screening,,
491,435030,1,2,,855848,457964,Inactive,15645703.0,899625.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
492,435030,1,2,,855848,457964,Inactive,15646160.0,899738.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
493,449728,1,2,,855848,457964,Inactive,,,,,Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability,Screening,,
494,449739,1,2,,855848,457964,Inactive,53832009.0,8912.0,,,Inhibitors of Cav3 T-type Calcium Channels: Primary Screen,Screening,,
495,449762,1,2,,855848,457964,Inactive,,,,IC50,High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media,Confirmatory,,
496,449768,1,1,,855848,457964,Inactive,7108463.0,6531.0,,,High Throughput Screening for Cocaine Antagonists: Primary Screen,Screening,,
497,463073,1,2,,855848,457964,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4),Screening,,
498,463075,1,1,,855848,457964,Inactive,,,,,HTS to identify inhibitors of TNF-alpha Induced Cell Death in Jurkat FADD-/- Cells.,Screening,,
499,463079,1,2,,855848,457964,Inactive,,,,,Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line,Screening,,
500,463082,1,1,,855848,457964,Inactive,270133071.0,7941.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH),Screening,,
501,463111,1,1,,855848,457964,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4),Screening,,
502,463115,1,1,,855848,457964,Inactive,119622516.0,5045.0,,,High throughput fluorescence intensity-based biochemical assay to screen for small molecule inhibitors of Furin conducted by the Pittsburgh Molecular Library Screening Center.,Screening,,
503,463141,1,2,,855848,457964,Inactive,14790119.0,836.0,,,Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3,Screening,,
504,463165,1,1,,855848,457964,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of   G-protein signaling 4 (RGS4),Screening,,
505,463187,1,1,,855848,457964,Inactive,,,,,384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC,Screening,,
506,463189,1,1,,855848,457964,Inactive,,,,,96-well format Chlamydomonas reinhardtii Algae Gravitaxis Assay to measure the difference in the absorbance between the small compact plug of WT swimming algae versus the MUT algae lacking cilia.,Screening,,
507,463193,1,1,,855848,457964,Inactive,31563518.0,84557.0,,,High-content cell-based screening for modulators of autophagy,Screening,,
508,463210,1,2,,855848,457964,Inactive,55960760.0,,,,Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7,Screening,,
509,463254,1,1,,855848,457964,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
510,464096,3,3,,103199841,457964,Active,,,0.48700000000000004,IC50,Inhibition of HCMV recombinant DNA polymerase expressed in baculovirus infected SF9 cells after 12 mins by scintillation proximity assay,Confirmatory,20167488.0,
511,464099,3,3,,103199841,457964,Active,,,0.473,IC50,Inhibition of Varicella zoster virus recombinant DNA polymerase expressed in baculovirus infected SF9 cells after 12 mins by scintillation proximity assay,Confirmatory,20167488.0,
512,481581,5,2,,103199841,457964,Active,,,0.48700000000000004,IC50,Inhibition of HCMV DNA polymerase infected in HFF cells,Confirmatory,20403696.0,
513,481584,5,2,,103199841,457964,Active,,,0.43799999999999994,IC50,Inhibition of HSV1 KOS DNA polymerase infected in african green monkey Vero cells,Confirmatory,20403696.0,
514,481586,5,2,,103199841,457964,Active,,,0.473,IC50,Inhibition of VZV KOS DNA polymerase infected in HFF cells,Confirmatory,20403696.0,
515,481809,8,5,,103199841,457964,Active,60392197.0,5422.0,2.6,IC50,Inhibition of human DNA polymerase alpha,Confirmatory,20403696.0,
516,485270,1,1,,855848,457964,Inactive,222080095.0,3061.0,,,FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
517,485272,1,1,,855848,457964,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS),Screening,,
518,485275,1,3,,855848,457964,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors,Screening,,
519,485281,1,1,,855848,457964,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
520,485281,1,1,,26751530,457964,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
521,485290,1,1,,855848,457964,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
522,485290,1,1,,26751530,457964,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
523,485294,1,1,,855848,457964,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
524,485297,1,1,,855848,457964,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
525,485298,1,1,,855848,457964,Inactive,,,,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
526,485313,1,2,,855848,457964,Inactive,255652944.0,4864.0,,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
527,485314,1,1,,855848,457964,Inactive,4505931.0,5423.0,,Potency,qHTS Assay for Inhibitors of DNA Polymerase Beta,Confirmatory,,
528,485317,1,2,,855848,457964,Inactive,54112432.0,2671.0,,,HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS,Screening,,
529,485341,1,1,,855848,457964,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
530,485344,1,1,,855848,457964,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists,Screening,,
531,485347,1,2,,855848,457964,Inactive,4503385.0,1813.0,,,HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators,Screening,,
532,485349,1,1,,855848,457964,Inactive,71902540.0,472.0,,Potency,qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia,Confirmatory,,
533,485350,1,2,,99300768,457964,Inactive,126642418.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme BasE,Screening,,
534,485353,2,1,,855848,457964,Inactive,30124074.0,1489680.0,,,qHTS of Yeast-based Assay for SARS-CoV PLP,Confirmatory,,
535,485358,1,1,,855848,457964,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists,Screening,,
536,485360,1,1,,855848,457964,Inactive,117938328.0,26013.0,,Potency,qHTS Assay for the Inhibitors of L3MBTL1,Confirmatory,,
537,485364,1,1,,855848,457964,Inactive,15149312.0,8345881.0,,Potency,qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins,Confirmatory,,
538,485367,1,2,,855848,457964,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
539,488806,1,2,,855848,457964,Inactive,148539876.0,156.0,,,RNA aptamer-based validation for inhibitors of GRK2,Screening,,
540,488837,1,1,,855848,457964,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
541,488847,1,3,,855848,457964,Inactive,148539876.0,156.0,,,RNA aptamer-based HTS for inhibitors of GRK2,Screening,,
542,488890,1,2,,855848,457964,Inactive,,,,IC50,"Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis",Confirmatory,,
543,488922,1,2,,855848,457964,Inactive,7706135.0,,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9,Screening,,
544,488975,1,2,,855848,457964,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT),Screening,,
545,488977,1,2,,855848,457964,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT),Screening,,
546,492947,1,1,,855848,457964,Inactive,4501969.0,154.0,,Potency,qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
547,493014,1,1,,855848,457964,Inactive,,,,Potency,qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
548,493033,1,2,,99300768,457964,Inactive,614089026.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme MbtI,Other,,
549,493056,1,1,,855848,457964,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers,Screening,,
550,493084,1,1,,855848,457964,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists.,Screening,,
551,493162,1,2,,99302286,457964,Active,335756.0,,,,A screen for compounds that inhibit processive DNA synthesis of vaccinia virus,Other,,
552,503599,3,3,,103199841,457964,Active,,,,,Inhibition of B-myb-mediated mitotic deffects in zebrafish bmyb mutant crb embryos at 10 ug/ml,Other,16372403.0,
553,503600,3,3,,103199841,457964,Active,,,,,Inhibition of B-myb-mediated mitotic deffects in zebrafish bmyb mutant crb embryos at 50 mM,Other,16372403.0,
554,503603,3,3,,103199841,457964,Active,,,,,Inhibition of B-myb-mediated mitotic deffects in zebrafish bmyb mutant embryo assessed as intra-Sphase and G2/M checkpoint inhibition at 10 ug/ml,Other,16372403.0,
555,503604,3,3,,103199841,457964,Active,,,,,Inhibition of B-myb-mediated mitotic deffects in zebrafish bmyb mutant embryo assessed as intra-Sphase and G2/M checkpoint inhibition in presence of 2 mM caffeine at 10 ug/ml,Other,16372403.0,
556,504327,1,1,,855848,457964,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
557,504327,1,1,,26751530,457964,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
558,504332,1,1,,855848,457964,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
559,504332,1,1,,26751530,457964,Inconclusive,168985070.0,,6.3096,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
560,504333,1,1,,855848,457964,Inactive,6683500.0,29994.0,,Potency,qHTS Assay for Inhibitors of BAZ2B,Confirmatory,,
561,504406,1,1,,855848,457964,Inactive,15610945.0,886142.0,,,Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6,Screening,,
562,504408,2,1,,855848,457964,Inactive,,,,,Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity,Screening,,
563,504459,1,3,,855848,457964,Inactive,4501969.0,154.0,,,HTS for Beta-2AR agonists via FAP method from Validation Set,Screening,,
564,504466,1,1,,855848,457964,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
565,504467,1,1,,855848,457964,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
566,504541,1,1,,855848,457964,Active,13177715.0,408.0,,,Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction for Validation Set,Screening,,
567,504600,1,2,,855848,457964,Inactive,6325022.0,855842.0,,,Validation of HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin,Screening,,
568,504651,1,1,,855848,457964,Inactive,4503383.0,1812.0,,,Potentiators of Human D1 Dopamine Receptor: qHTS,Screening,,
569,504652,1,1,,855848,457964,Inactive,4503383.0,1812.0,,,Antagonist of Human D 1 Dopamine Receptor: qHTS,Screening,,
570,504660,1,1,,855848,457964,Inactive,4503383.0,1812.0,,,Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS,Screening,,
571,504706,1,1,,855848,457964,Inactive,23491729.0,7157.0,,Potency,qHTS assay for re-activators of p53 using a Luc reporter,Confirmatory,,
572,504810,1,2,,855848,457964,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
573,504812,1,2,,855848,457964,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
574,504832,1,1,,855848,457964,Active,,,0.5221,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
575,504834,1,1,,855848,457964,Active,,,0.5858,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
576,504842,1,1,,855848,457964,Inactive,4090929.0,10576.0,,Potency,Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS,Confirmatory,,
577,504845,1,1,,26751530,457964,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
578,504847,1,1,,26751530,457964,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
579,512139,1,4,,103199841,457964,Unspecified,,,,,Antiviral activity against HSV1 infected in african green monkey Vero cells after 6 hrs by plaque reduction assay,Other,20691339.0,
580,512140,1,4,,103199841,457964,Unspecified,,,,,Antiviral activity against HSV1 infected in african green monkey Vero cells assessed as minimum antiviral concentration after 6 hrs,Other,20691339.0,
581,512141,4,2,,103199841,457964,Active,,,0.58,IC50,Cytotoxicity against african green monkey Vero cells assessed as loss of monolayer present around the plaques,Confirmatory,20691339.0,
582,540256,1,2,,855848,457964,Inconclusive,,,0.7308,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
583,540275,1,1,,855848,457964,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1,Screening,,
584,540276,1,2,,855848,457964,Active,420597.0,,0.5174,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
585,540277,1,1,,855848,457964,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1,Screening,,
586,540299,1,2,,99302286,457964,Inactive,15607688.0,887529.0,,,A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis,Other,20850304.0,
587,547083,7,5,,103199841,457964,Active,60392197.0,5422.0,16.0,IC50,Inhibition of human DNA polymerase alpha assessed as incorporation of [alpha-32P]dCTP up to 1mM preincubated for 30 mins by whatman DE81 paper binding assay,Confirmatory,20516278.0,
588,547084,4,7,,103199841,457964,Unspecified,544186.0,5423.0,100.0,IC50,Inhibition of human DNA polymerase beta assessed as incorporation of [alpha-32P]dCTP up to 1mM preincubated for 30 mins by whatman DE81 paper binding assay,Confirmatory,20516278.0,
589,547085,7,5,,103199841,457964,Unspecified,1706507.0,5428.0,100.0,IC50,Inhibition of human DNA polymerase gamma assessed as incorporation of [alpha-32P]dCTP up to 1mM preincubated for 30 mins by whatman DE81 paper binding assay,Confirmatory,20516278.0,
590,588342,1,1,,855848,457964,Inactive,160794.0,,,Potency,qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project),Confirmatory,,
591,588368,1,2,,855848,457964,Inactive,,,,,HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies from validation set,Screening,,
592,588459,1,2,,855848,457964,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set",Screening,16604538.0,
593,588459,1,2,,855848,457964,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set",Screening,20035615.0,
594,588459,1,2,,855848,457964,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set",Screening,20938917.0,
595,588460,1,2,,855848,457964,Inactive,,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set",Screening,16604538.0,
596,588460,1,2,,855848,457964,Inactive,,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set",Screening,20035615.0,
597,588460,1,2,,855848,457964,Inactive,,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set",Screening,20938917.0,
598,588461,1,2,,855848,457964,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set",Screening,16604538.0,
599,588461,1,2,,855848,457964,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set",Screening,20035615.0,
600,588461,1,2,,855848,457964,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set",Screening,20938917.0,
601,588506,1,2,,855848,457964,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors with Validation compound Set,Screening,,
602,588511,1,2,,855848,457964,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A),Screening,,
603,588519,1,2,,99300768,457964,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
604,588519,1,2,,99302286,457964,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
605,588550,1,1,,855848,457964,Inactive,9955963.0,10058.0,,,Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for Validation Compound Set,Screening,,
606,588579,1,1,,26751530,457964,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
607,588627,1,1,,855848,457964,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling,Screening,,
608,588675,1,1,,855848,457964,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling,Screening,,
609,588676,1,1,,855848,457964,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling,Screening,,
610,588685,1,1,,855848,457964,Inactive,,3205.0,,,HTS to identify compounds that promote myeloid differentiation with Validation compound set,Screening,,
611,602276,1,1,,855848,457964,Inactive,20140422.0,7098.0,,,Novel Modifiers of Toll-like and RIG-like Receptor Signaling-SeV Stimulus,Screening,,
612,602277,1,1,,855848,457964,Inactive,20140422.0,7098.0,,,Novel Modifiers of Toll-like and RIG-like Receptor Signaling-Poly IC Stimulus,Screening,,
613,602314,1,2,,99300768,457964,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
614,602332,1,1,,26751530,457964,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
615,624296,1,1,,855848,457964,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
616,624297,1,1,,855848,457964,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
617,651820,1,1,,855848,457964,Inactive,,,,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
618,686978,1,1,,26751530,457964,Active,79154014.0,55775.0,0.131,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
619,686979,1,1,,26751530,457964,Active,79154014.0,55775.0,0.1041,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
620,697852,1,7,,103199841,457964,Unspecified,14916521.0,,,,Inhibition of electric eel AChE at 2 mg/ml by Ellman's method,Other,23062825.0,
621,697853,1,7,,103199841,457964,Unspecified,21362409.0,100033901.0,,,Inhibition of horse BChE at 2 mg/ml by Ellman's method,Other,23062825.0,
622,720532,1,1,,26751530,457964,Inconclusive,420597.0,,31.6228,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
623,720533,1,1,,26751530,457964,Inconclusive,,,39.8107,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
624,720579,2,1,,26751530,457964,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
625,720580,1,1,,26751530,457964,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
626,720717,1,3,,92309854,457964,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
627,1085521,1,2,,103199841,457964,Inconclusive,,,,,Antifungal activity against Candida albicans at 500 ug/disk after 72 hr by disk diffusion method,Other,,
628,1085524,1,2,,103199841,457964,Inconclusive,,,,,Antibacterial activity against Escherichia coli at 500 ug/disk after 24 hr by disk diffusion method,Other,,
629,1085530,1,2,,103199841,457964,Inconclusive,,,,,Antibacterial activity against Bacillus subtilis at 500 ug/disk after 24 hr by disk diffusion method,Other,,
630,1085531,1,2,,103199841,457964,Unspecified,,,,,Antiviral activity against Human herpesvirus 1 infected African green monkey Vero cells assessed as reduction of virus induced plaque formation after 66 hr,Other,,
631,1085532,3,1,,103199841,457964,Unspecified,,,,,Cytotoxicity against Chlorocebus aethiops (African green monkey) Vero cells,Other,,
632,1085533,1,2,,103199841,457964,Unspecified,,,,,Antiviral activity against Human herpesvirus 1 infected African green monkey Vero cells assessed as reduction of virus induced plaque formation at 20 mg/ml after 66 hr,Other,,
633,1096100,1,2,,103199841,457964,Unspecified,,,,,Cytotoxicity against Chlorocebus aethiops (African green monkey) Vero cells assessed as concentration required for 50% loss of monolayer around viral plaque after 66 hr,Other,,
634,1096101,1,2,,103199841,457964,Unspecified,,,,,Antiviral activity against Human herpesvirus 1 infected Vero cells after 66 hr,Other,,
635,1096102,1,2,,103199841,457964,Unspecified,,,,,Antiviral activity against Human herpesvirus 1 infected Vero cells assessed as reduction in viral plaque after 66 hr relative to control,Other,,
636,1110335,1,2,,103199841,457964,Inactive,,,,,Cytotoxicity against Spodoptera frugiperda (fall armyworm) Sf9 cells at 5 uM after 72 hr by trypan blue dye exclusion test,Other,,
637,1117319,1,2,,855848,457964,Inconclusive,9629361.0,155459.0,,Average IC50,High Throughput Screen to Identify Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G:#A time-resolved fluorescence resonance energy transfer (TR-FRET) assay for HIV-1 Vif-APOBEC3G interaction,Confirmatory,,
638,1117319,1,2,,855848,457964,Inconclusive,13399304.0,60489.0,,Average IC50,High Throughput Screen to Identify Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G:#A time-resolved fluorescence resonance energy transfer (TR-FRET) assay for HIV-1 Vif-APOBEC3G interaction,Confirmatory,,
639,1121502,1,1,,103199841,457964,Active,,,7.17,IC50,Inhibition of DNA polymerase alpha (unknown origin),Confirmatory,,
640,1121503,1,1,,103199841,457964,Active,,,1.96,IC50,Inhibition of DNA polymerase beta (unknown origin),Confirmatory,,
641,1155638,1,1,,103199841,457964,Active,,,19.6,IC50,Inhibition of calf thymus DNA polymerase alpha assessed as incorporation of [3H]dTTP into poly(dA)/oligo(dT)18 DNA-template primer after 60 mins,Confirmatory,24926891.0,
642,1155639,1,3,,103199841,457964,Unspecified,585064.0,29240.0,100.0,IC50,Inhibition of rat recombinant DNA polymerase beta expressed in Escherichia coli JMpbeta5 cells assessed as incorporation of [3H]dTTP into poly(dA)/oligo(dT)18 DNA-template primer after 60 mins,Confirmatory,24926891.0,
643,1155640,1,1,,103199841,457964,Active,,,9.0,IC50,Cytotoxicity against human HCT116 cells assessed as inhibition of cell proliferation after 24 hrs by WST-1 assay,Confirmatory,24926891.0,
644,1159524,1,1,,26751530,457964,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
645,1224864,1,2,,316934864,457964,Inactive,,,,,HCS microscopy assay (F508del-CFTR),Screening,27732613.0,
646,1259389,1,1,,175608060,457964,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
647,1259407,1,1,,363899733,457964,Active,,,,,CCRIS mutagenicity studies,Other,,
648,1259408,1,1,,363897321,457964,Active,,,,,GENE-TOX mutagenicity studies,Other,,
649,1259416,1,2,,340083791,457964,Active,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
650,1259421,1,1,,340083791,457964,Active,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
